MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Oncology Software Update Compliant with New BTS Guidelines

By MedImaging International staff writers
Posted on 24 Aug 2015
Image: Siemens Healthcare’s syngo.via MM Oncology facilitates compliance by clinicians to British Thoracic Society guidelines for the investigation and management of pulmonary nodules.(Photo courtesy of Siemens Healthcare).
Image: Siemens Healthcare’s syngo.via MM Oncology facilitates compliance by clinicians to British Thoracic Society guidelines for the investigation and management of pulmonary nodules.(Photo courtesy of Siemens Healthcare).
A key diagnostic imaging vendor has announced that it has modified its oncology software solution to ensure compliance with new British Thoracic Society (BTS) guidelines for lung nodule screening.

The BTS developed the new evidence-based algorithms and recommendations to save clinicians time and improve outcomes for lung cancer patients. Improved estimations of the size and growth rate of lung nodules are vital in helping oncologists understand whether a nodule is cancerous, and to help them decide on treatment options. According to Cancer Research UK (London, UK) lung cancer is the second most common cancer in the UK, accounting for 13% of all new cases of cancer.

The syngo.via MM Oncology software solution was developed by Siemens Healthcare (Erlangen, Germany) and should help oncologists comply with key areas of the new guidelines. According to the guidelines, automated or semi-automated volumetric measurement is the preferred method for assessing coin lesions, and is more accurate than diameter measurements. Siemens Healthcare’s software solution can help clinicians measure nodule volumes, and quantify growth rates or reduction of nodules between the initial and the follow up scans.

Greg Baker, lead applications specialist User Services and syngo.via at Siemens Healthcare, said, “As standard, all of our customers using syngo.via are provided with a range of fully automated tools specifically designed to support clinicians in the detection, segmentation and evaluation of suspicious lesions including dedicated tools for the volumetric measurement of pulmonary nodules. The guidelines from BTS are a welcome change to ensure accuracy in measurement and evaluation. We are looking forward to working with our customers to assist with guideline compliance so clinicians are able to receive the valuable information they need to make a confident diagnosis.”

Related Links:

Siemens Healthcare
Cancer Research UK


High-Precision QA Tool
DEXA Phantom
New
Mammo DR Retrofit Solution
DR Retrofit Mammography
Biopsy Software
Affirm® Contrast
Post-Processing Imaging System
DynaCAD Prostate

Channels

Nuclear Medicine

view channel
Image: Perovskite crystal boules are grown in carefully controlled conditions from the melt (Photo courtesy of Mercouri Kanatzidis/Northwestern University)

New Camera Sees Inside Human Body for Enhanced Scanning and Diagnosis

Nuclear medicine scans like single-photon emission computed tomography (SPECT) allow doctors to observe heart function, track blood flow, and detect hidden diseases. However, current detectors are either... Read more

General/Advanced Imaging

view channel
Image: The Angio-CT solution integrates the latest advances in interventional imaging (Photo courtesy of Canon Medical)

Cutting-Edge Angio-CT Solution Offers New Therapeutic Possibilities

Maintaining accuracy and safety in interventional radiology is a constant challenge, especially as complex procedures require both high precision and efficiency. Traditional setups often involve multiple... Read more